Health Care Insider Trading Activity
Over the last 30 days, corporate insiders across 508 Health Care companies filed 308 purchases totaling $307.01M and 1,898 sales totaling $2.69B. The most-active Health Care companies by insider filings are listed below.
Most-active companies
200Showing companies 101 to 150 of 200 by distinct insiders filing.
| # | Ticker / Company | Insiders (30d) | Insider buys (30d) |
|---|---|---|---|
| 101 | 2 | - | |
| 102 | 2 | - | |
| 103 | 2 | $25.07M | |
| 104 | 2 | - | |
| 105 | 2 | - | |
| 106 | 2 | - | |
| 107 | 2 | - | |
| 108 | 2 | - | |
| 109 | 2 | - | |
| 110 | 2 | $7.04M | |
| 111 | 2 | - | |
| 112 | 2 | - | |
| 113 | 2 | - | |
| 114 | 2 | - | |
| 115 | 2 | - | |
| 116 | 2 | - | |
| 117 | 2 | - | |
| 118 | 2 | - | |
| 119 | 2 | - | |
| 120 | 2 | - | |
| 121 | 2 | $3.00M | |
| 122 | 2 | - | |
| 123 | 2 | - | |
| 124 | 2 | - | |
| 125 | 2 | - | |
| 126 | 2 | - | |
| 127 | 2 | - | |
| 128 | 2 | - | |
| 129 | 2 | $1.67M | |
| 130 | 2 | - | |
| 131 | 2 | - | |
| 132 | 2 | $1.16M | |
| 133 | 2 | $500K | |
| 134 | 2 | $1.00M | |
| 135 | 2 | $564K | |
| 136 | 2 | $450K | |
| 137 | 2 | $352K | |
| 138 | 2 | $111K | |
| 139 | 2 | $100K | |
| 140 | 2 | $100K | |
| 141 | 2 | $7K | |
| 142 | 2 | $87K | |
| 143 | 2 | $83K | |
| 144 | 2 | $71K | |
| 145 | 2 | $60K | |
| 146 | 2 | $49K | |
| 147 | 2 | $40K | |
| 148 | 2 | $10K | |
| 149 | 1 | - | |
| 150 | 1 | - |
Industries in this sector
10- Pharmaceutical Preparations - 212 companies
- Biological Products, (No Diagnostic Substances) - 77 companies
- Surgical & Medical Instruments & Apparatus - 72 companies
- Laboratory Analytical Instruments - 18 companies
- Services-Medical Laboratories - 18 companies
- Orthopedic, Prosthetic & Surgical Appliances & Supplies - 17 companies
- Electromedical & Electrotherapeutic Apparatus - 16 companies
- Medicinal Chemicals & Botanical Products - 10 companies
- Hospital & Medical Service Plans - 9 companies
- In Vitro & In Vivo Diagnostic Substances - 8 companies
Reading a sector
Sales normally dwarf purchases here, and that is the baseline rather than a warning. Executives are paid in stock and sell to diversify or to cover the tax due when awards vest, so a large sell total across a sector usually reflects a vesting calendar. Buying is the informative side, because an insider purchasing on the open market is spending their own money on a company they already understand.
Companies are ranked by distinct insiders filing rather than by dollar value, which surfaces the cluster case: several people inside the same business acting in the same window. Where a company reports only an SEC SIC code, it is mapped into these sectors through a standard crosswalk, so the grouping reflects what a business does rather than how it happens to file.